Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 43,296 $ 2,595
Restricted cash 1,127 630
Accounts receivable 10,877 5,548
Short-term investments 150,740 279,374
Prepaid expenses and other current assets 12,086 6,798
Total current assets 218,126 294,945
Non-current assets:    
Property and equipment, net 2,037 2,045
Investment in joint venture 390 200
Intangible assets, net 46,365 24,421
Goodwill 39,445 13,328
Operating right-of-use asset 17,692 713
Other non-current assets 970 232
Total assets 325,025 335,884
Current liabilities:    
Accounts payable and accrued expenses 16,536 6,369
Deferred revenue 6,709 5,976
Operating lease liability, current 3,362 438
Total current liabilities 26,607 12,783
Non-current liabilities:    
Warrant liability 7,083 31,308
Operating lease liability, long-term 14,970 278
Deferred tax liability 1,876 144
Total liabilities 50,536 44,513
Commitments and Contingencies (Note 13)
Stockholders' Equity    
Preferred stock, $0.0001 par value, 2,000,000 shares authorized at December 31, 2022 and December 31, 2021. No shares issued and outstanding at December 31, 2022 and December 31, 2021. 0 0
Common stock, $0.0001 par value; 400,000,000 authorized; 71,660,617 and 70,667,381 shares issued at December 31, 2022 and December 31, 2021, respectively. 7 7
Additional paid in capital 375,873 368,680
Accumulated other comprehensive income (loss) 2,287 (898)
Accumulated deficit (103,678) (76,418)
Total stockholders' equity 274,489 291,371
Total Liabilities and Stockholders' Equity $ 325,025 $ 335,884